Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Nelfinavir mesylate
Trade Name
Viracept
Manufacturer
Pfizer
Risk Category
B
  • Controlled studies done on animals in reproduction do not indicate risk to the fetus.
  • No adequate and well-controlled studies done on pregnant women.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • A systemic antiviral drug used in the treatment of human hiv infection.
  • Fetal Risk
    Fetal Risk
  • Inadequate human studies.
  • Animal studies revealed no maternal or fetal adverse effects.
  • Breast Feeding
    Breast Feeding
  • Unknown excretion into human breast milk.
  • Breast feeding is not recommended in hiv infected mothers due to the risk of postnatal transmission.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     6   +   2    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year